Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026)
Xenon Pharmaceuticals (XENE) reported Exchange Rate Effect of -$130000.0 for Q1 2026, down 103.12% year-over-year from $4.2 million in Q1 2025, and down 25.0% quarter-over-quarter from -$104000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Exchange Rate Effect data on file, last reported at -$130000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$130000.0, down 103.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $392000.0 (up 128.63% YoY), and the FY2025 annual result was $458000.0, up 127.39% from the prior year.
- Exchange Rate Effect retreated to -$130000.0 in Q1 2026 per XENE's latest filing, from -$104000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $814000.0 in Q4 2022 and troughed at -$2.7 million in Q3 2022.
- A 5-year average of -$203058.8 and a median of -$64000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect soared 1079.71% in 2022, then slumped 722.03% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $814000.0 in 2022, then plunged by 69.78% to $246000.0 in 2023, then slumped by 570.33% to -$1.2 million in 2024, then surged by 91.01% to -$104000.0 in 2025, then fell by 25.0% to -$130000.0 in 2026.
- Business Quant data shows XENE's Exchange Rate Effect at -$130000.0 in Q1 2026, -$104000.0 in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | 54,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -367,000.00 |
| Mar 31, 2024 | -367,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Dec 31, 2023 | 246,000.00 |